A study has found that the analysis of biomarkers in the urine samples of kidney transplant recipients can diagnose transplant rejection, even before it occurs. [ + ]

A new group of therapies is showing promise for the treatment of haemophilia. [ + ]

The RACI Division of Biomolecular Chemistry will hold its 2013 conference in the Blue Mountains in July. With themes of medicinal chemistry, chemical biology and drug discovery, here is a taste of what the meeting has in store. [ + ]

Particle and Surface Sciences Australia has reported on how nanoparticle tracking analysis (NTA), from Nanosight UK, is being implemented for the further characterisation of natural colloids (inorganic and organic) at the Institute of Water Resources and Water Supply at the Technical University Hamburg-Harburg in Germany. [ + ]

AmpliPhi and US army researchers will collaborate on treatments for antibiotic-resistant bacterial infections including Staphylococcus aureus. [ + ]

Instead of relying on heavy metals as catalysts, researchers have discovered a way to use iron which will make the process of hydrogenation both more environmentally friendly and less expensive. [ + ]

Europe PubMed Central (Europe PMC), a public archive of 28 million abstracts and 2.6 million full-text articles, has teamed with Researchfish, an online system for tracking and reporting on research outcomes. [ + ]

For decades, electronic devices have been getting smaller, and smaller, and smaller. It’s now possible - even routine - to place millions of transistors on a single silicon chip. But transistors based on semiconductors can only get so small. [ + ]

Phylogica (ASX:PYC) has improved its Phylomer peptide screening platform to allow it to discover candidates that can penetrate cell walls and deliver drug cargoes to a specific target. [ + ]

Global Medisafe Holdings has launched its first Clik-Lok safety syringe product in Europe and will soon start the process of securing Australian approval. [ + ]

The RACI Division of Biomolecular Chemistry will hold its 2013 conference in the Blue Mountains in July. With themes of medicinal chemistry, chemical biology and drug discovery, here is a taste of what the meeting has in store. [ + ]

Prima BioMed (ASX:PRR) has announced phase II trials for cancer treatment candidate CVac in pancreatic, colorectal and breast cancers. [ + ]

A new process for making a three-dimensional microstructure that can be used in the analysis of cells could prove useful in counterterrorism measures and in water and food safety concerns. [ + ]

When Curtin University’s renewable energy research centre CRESTA closed in 2004, the university found itself lacking a facility devoted to renewable energy. So when Dr Sumedha Rajakaruna was asked to design and build a new lab, he made sure the full use of expensive renewable energy sources could be achieved. [ + ]

The French Government has agreed to fund a two-year economic impact study of GI Dynamics’ (ASX:GID) EndoBarrier Therapy in obesity and type 2 diabetes. [ + ]